Assertio Holdings | DEPO - Pre Tax Profit


Assertio Holdings reported $-2.88M in Pre-Tax Profit for its fiscal quarter ending in September of 2024.





Pre Tax Profit Change Date
ANI Pharmaceuticals USD 31.48M 18.04M Dec/2025
Assertio Holdings USD -2.88M 648K Sep/2024
Aurora Cannabis CAD -1.58M 48.55M Dec/2025
Cara Therapeutics USD -4.91M 3.17M Mar/2025
Daiichi Sankyo JPY 106.73B 48.96B Dec/2025
Ironwood Pharmaceuticals USD 68.02M 30.2M Sep/2025
J&J USD 7.82B 2.86B Mar/2026
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Merck USD 3.42B 3.32B Dec/2025
Nektar Therapeutics USD -34.7M 2.35M Dec/2025
Omeros USD -65.12M 21.27M Jun/2024
Pfizer USD 5.18B 6.82B Mar/2026
Teva Pharmaceutical Industries USD 753M 662M Mar/2026